BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28175931)

  • 1. Determining Patient Preferences for Indeterminate Thyroid Nodules: Observation, Surgery or Molecular Tests.
    Lee DJ; Xu JJ; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Rotstein LE; Goldstein DP; de Almeida JR
    World J Surg; 2017 Jun; 41(6):1513-1520. PubMed ID: 28175931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
    Witt RL
    Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.
    Sacks WL; Bose S; Zumsteg ZS; Wong R; Shiao SL; Braunstein GD; Ho AS
    Cancer Cytopathol; 2016 Oct; 124(10):722-728. PubMed ID: 27347838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules.
    Park KT; Ahn SH; Mo JH; Park YJ; Park DJ; Choi SI; Park SY
    Head Neck; 2011 Feb; 33(2):160-5. PubMed ID: 20848434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a gene expression classifier on the long-term management of patients with cytologically indeterminate thyroid nodules.
    Singer J; Hanna JW; Visaria J; Gu T; McCoy M; Kloos RT
    Curr Med Res Opin; 2016 Jul; 32(7):1225-32. PubMed ID: 26973059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
    Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
    Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
    Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Gene Expression Classifier Molecular Testing on the Surgical Decision-Making Process for Patients With Thyroid Nodules.
    Noureldine SI; Olson MT; Agrawal N; Prescott JD; Zeiger MA; Tufano RP
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1082-8. PubMed ID: 26606459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules.
    Dharampal N; Smith K; Harvey A; Paschke R; Rudmik L; Chandarana S
    J Otolaryngol Head Neck Surg; 2022 Dec; 51(1):46. PubMed ID: 36544210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with standardized thyroid fine-needle aspiration reporting categories: follow-up data from 529 cases with "indeterminate" or "atypical" reports.
    Nga ME; Kumarasinghe MP; Tie B; Sterrett GF; Wood B; Walsh J; Nguyen H; Whyte A; Frost FA
    Cancer Cytopathol; 2010 Dec; 118(6):423-33. PubMed ID: 20945329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients.
    Lew JI; Snyder RA; Sanchez YM; Solorzano CC
    J Am Coll Surg; 2011 Jul; 213(1):188-94; discussion 194-5. PubMed ID: 21601489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.
    Baca SC; Wong KS; Strickland KC; Heller HT; Kim MI; Barletta JA; Cibas ES; Krane JF; Marqusee E; Angell TE
    Cancer Cytopathol; 2017 May; 125(5):313-322. PubMed ID: 28152275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of molecular diagnostic testing in the management of thyroid nodules.
    Moore MD; Panjwani S; Gray KD; Finnerty BM; Zarnegar R; Fahey TJ
    Expert Rev Mol Diagn; 2017 Jun; 17(6):567-576. PubMed ID: 28423960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
    Nikiforov YE; Steward DL; Robinson-Smith TM; Haugen BR; Klopper JP; Zhu Z; Fagin JA; Falciglia M; Weber K; Nikiforova MN
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2092-8. PubMed ID: 19318445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the Bethesda criteria risk stratification of thyroid nodules.
    Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
    Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: a prospective case series of 960 patients.
    Kleiman DA; Sporn MJ; Beninato T; Crowley MJ; Nguyen A; Uccelli A; Scognamiglio T; Zarnegar R; Fahey TJ
    Cancer; 2013 Apr; 119(8):1495-502. PubMed ID: 23280049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the BRAF mutation analysis in calcified thyroid nodules.
    Yoo EY; Shin JH; Ko EY; Han BK
    AJR Am J Roentgenol; 2012 Apr; 198(4):891-5. PubMed ID: 22451557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.
    Nam SY; Han BK; Ko EY; Kang SS; Hahn SY; Hwang JY; Nam MY; Kim JW; Chung JH; Oh YL; Shin JH
    Thyroid; 2010 Mar; 20(3):273-9. PubMed ID: 20187782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules.
    Li H; Robinson KA; Anton B; Saldanha IJ; Ladenson PW
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1719-26. PubMed ID: 21865367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.